SCIESCOPUSQ1
LANCET ONCOLOGY
ELSEVIER SCIENCE INC, United Kingdom
LANCET ONCOLOGY is an academic journal published by ELSEVIER SCIENCE INC (United Kingdom). Identifiers: ISSN 1470-2045, eISSN 1474-5488. Indexed in SCIE, SCOPUS. Metrics: JIF 35.9, CiteScore 50.8, SJR 11.319, SNIP 10.22. Subject areas: ONCOLOGY. tlooto lists 11,633 papers from this journal.
CiteScore
50.80
Scopus citation metric
SJR
11.319
SCImago rank
SNIP
10.22
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1470-2045
- eISSN
- 1474-5488
- Abbreviation
- LANCET ONCOL
- Publisher
- ELSEVIER SCIENCE INC
- Country
- United Kingdom
Web of Science categories
SCIEONCOLOGY
Scopus ASJC categories
2730 Oncology
Keywords
Oncology
Papers in this journal
Recent papers
Most cited papers
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
2009 · 7,270 citations
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
2009 · 5,300 citations
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
2012 · 5,232 citations
- Definition and classification of cancer cachexia: an international consensus.
2011 · 4,888 citations
- International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
2014 · 4,191 citations